Theralase Technologies Inc. Capital Reinvestment Ratio
Theralase Technologies Inc. capital reinvestment ratio. Theralase Technologies Inc. (TLT) has a Capital Reinvestment Ratio of 0.05x as of September 2018, meaning it reinvests 0% of its operating cash flow (CA$436.21K) in capital expenditures (CA$19.98K). Check Theralase Technologies Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Theralase Technologies Inc. (2005–2005)
Capital reinvestment ratio of Theralase Technologies Inc. from 2005 to 2005. This chart tracks Theralase Technologies Inc.'s Capital Reinvestment Ratio across 1 annual periods. Also explore Theralase Technologies Inc. net asset momentum to track the company's year-over-year net asset growth rate.
Theralase Technologies Inc. Capital Reinvestment Ratio by Year (2005–2005)
Theralase Technologies Inc. capital reinvestment ratio by year from 2005 to 2005. For the full cash flow conversion analysis, see Theralase Technologies Inc. cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2005 | 1.00x | CA$85.33K | CA$85.30K | — |